v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities:    
Net income $ 121,602 $ 108,703
Adjustments to reconcile net income to net cash provided from operating activities:    
Depreciation of property and equipment 17,529 16,347
Amortization of intangible assets 3,195 3,156
Noncash lease expense 4,759 4,804
Impairment of strategic investment 4,719 0
Equity-based compensation 27,674 27,038
Deferred income tax 19,306 701
Amortization of revolver loan costs 99 169
Gain on divestiture of a business (635) 0
Premium amortization and (discount accretion), net on marketable securities (744) (6,330)
Changes in operating assets and liabilities:    
Accounts receivable (1,285) (113)
Prepaid expenses and other assets (500) (4,379)
Prepaid revenue share fee (1,842) (777)
Accounts payable (6,160) (475)
Accrued and other long term liabilities (36,147) (26,304)
Deferred revenue 30,046 40,825
Operating lease liabilities (7,584) (4,300)
Net cash provided by operating activities 174,032 159,065
Investing activities:    
Purchases of marketable securities (475,971) (703,132)
Sales of marketable securities 565,072 861,683
Proceeds from divestiture 2,700 0
Purchase of strategic investment (514) (1,000)
Purchases of property and equipment (18,318) (9,259)
Purchases of intangible assets 0 (318)
Net cash provided by investing activities 72,969 147,974
Financing activities:    
Repurchase of Class A Common Stock (126,345) (225,160)
Payment of dividend (35,621) (27,218)
Payment of special dividend (25,316) (28,828)
Distributions to members (14,310) (20,114)
Tax distribution to members (26,096) (24,979)
Payment of taxes on net settled stock-based awards (10,881) (6,729)
Other financing activities (334) (154)
Net cash used in financing activities (238,903) (333,182)
Net increase (decrease) in cash, cash equivalents, and restricted cash 8,098 (26,143)
Cash, cash equivalents, and restricted cash, beginning of period 70,348 62,401
Exchange rate effect on cash and cash equivalents, and restricted cash 85 37
Cash, cash equivalents, and restricted cash, end of period $ 78,531 $ 36,295

Source